Israel Englander Amarin Corp Plcuk Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.63 - $1.07 $754,596 - $1.28 Million	-1,197,773 Reduced 77.53%	347,056 $239,000
Q1 2024 May 15, 2024	SELL	$0.82 - $1.35 $814,888 - $1.34 Million	-993,767 Reduced 39.15%	1,544,829 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$0.66 - $0.91 $50,761 - $69,989	76,912 Added 3.12%	2,538,596 $2.21 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.49 $3.77 Million - $5.01 Million	-3,362,066 Reduced 57.73%	2,461,684 $2.93 Million
Q1 2023 May 15, 2023	SELL	$1.19 - $2.19 $1.31 Million - $2.41 Million	-1,100,051 Reduced 15.89%	5,823,750 $8.74 Million
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $5.52 Million - $6.91 Million	5,158,279 Added 292.17%	6,923,801 $8.38 Million
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $851,603 - $1.3 Million	-781,288 Reduced 30.68%	1,765,522 $1.92 Million
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $2.64 Million - $8.63 Million	-2,338,574 Reduced 47.87%	2,546,810 $3.8 Million
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $4.32 Million - $5.65 Million	1,515,872 Added 44.99%	4,885,384 $16.1 Million
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $6.58 Million - $10.5 Million	2,030,046 Added 151.56%	3,369,512 $11.4 Million
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $2.45 Million - $3.63 Million	-620,909 Reduced 31.67%	1,339,466 $6.83 Million
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $4.78 Million - $7.29 Million	-1,121,473 Reduced 36.39%	1,960,375 $8.59 Million
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $2.66 Million - $4.65 Million	-528,288 Reduced 14.63%	3,081,848 $19.1 Million
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $6.79 Million - $8.93 Million	1,681,450 Added 87.18%	3,610,136 $17.7 Million
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $9.28 Million - $19.8 Million	-2,550,374 Reduced 56.94%	1,928,686 $8.12 Million
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $9.64 Million - $16.7 Million	2,016,805 Added 81.91%	4,479,060 $31 Million
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $3.69 Million - $19.9 Million	923,731 Added 60.04%	2,462,255 $9.85 Million
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $42.2 Million - $73 Million	-3,026,124 Reduced 66.29%	1,538,524 $33 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $24.3 Million - $40.5 Million	1,749,742 Added 62.16%	4,564,648 $69.2 Million
Q2 2019 Aug 15, 2019	BUY	$16.27 - $20.51 $44 Million - $55.4 Million	2,703,280 Added 2421.73%	2,814,906 $54.6 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $49.7 Million - $62.7 Million	-3,055,811 Reduced 96.48%	111,626 $19.3 Million
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $31 Million - $54.9 Million	-2,456,894 Reduced 43.68%	3,167,437 $65.8 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $43.6 Million - $80.7 Million	3,511,705 Added 166.22%	5,624,331 $76.5 Million
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $4.55 Million - $30.2 Million	-1,855,351 Reduced 46.76%	2,112,626 $34.4 Million
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $2.43 Million - $3.16 Million	-907,180 Reduced 18.61%	3,967,977 $12.3 Million
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $5.02 Million - $7.46 Million	1,680,136 Added 52.59%	4,875,157 $14.7 Million
Q4 2017 Feb 14, 2018	SELL	$3.06 - $4.09 $849,119 - $1.13 Million	-277,490 Reduced 7.99%	3,195,021 $12.8 Million
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $10.5 Million - $12.9 Million	3,472,511	3,472,511 $12.2 Million

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$12.4 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$6.21 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.65 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.27 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.25 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account